Effective Removal of Dabigatran by Idarucizumab or Hemodialysis: A Physiologically Based Pharmacokinetic Modeling Analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Effective Removal of Dabigatran by Idarucizumab or Hemodialysis: A Physiologically Based Pharmacokinetic Modeling Analysis ; day:4 ; month:2 ; year:2020 ; pages:1-17
Clinical pharmacokinetics ; (4.2.2020), 1-17
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40262-019-00857-y
- URN
-
urn:nbn:de:101:1-2020050419124414318487
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fuhr, Laura Maria
- Hanke, Nina
- Meibohm, Bernd
- Lehr, Thorsten
- SpringerLink (Online service)
Other Objects (12)
Removal of dabigatran is superior by sustained low efficient dialysis (SLED) compared to intermittent hemodialysis
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Removal of dabigatran is superior by sustained low efficient dialysis (SLED) compared to intermittent hemodialysis
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Removal of dabigatran is superior by sustained low efficient dialysis (SLED) compared to intermittent hemodialysis
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Adapting physiologically-based pharmacokinetic models for machine learning applications
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Physiologically-based pharmacokinetic modelling for the prediction of adverse drug reactions
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat